Measurement of radiation absorbed dose in endovascular ho-166 brachytherapy using a balloon angio-catheter

Nuclear Medicine Communications

Volumn 21, Issue 10, 2000, Pages 959-964

  JOH, C W ^a   PARK, C H ^a   KANG, H J ^a   OH, Y T ^b   CHUN, M S ^b   KIM, H S ^b   CHOI, B I W ^b   PARK, K B ^c   KIM, Y M ^c   KIM, K H ^c   VAHC, Y W ^c   JANG, J S ^c   LEE, B K ^c  

^a Ajou University School of Medicine   (South Korea)

^b Yonsei University Wonju   (South Korea)

^c Kyonggi University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HOLMIUM; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BRACHYTHERAPY; CORONARY ARTERY DISEASE; HUMAN; IMAGE QUALITY; METHODOLOGY; RADIATION DOSE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BRACHYTHERAPY; CORONARY DISEASE; HOLMIUM; HUMANS; PHANTOMS, IMAGING; RADIOISOTOPES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE;

EID: 0034297224     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200010000-00011     Document Type: Article

References (16)

1. Pepine CJ, Hirshfeld JW, Macdonald RG et al. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. Circulation 1990; 81: 1753-1761.
2. The Multicenter European Research Trial with Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after PTCA? Circulation 1992; 86: 100-110.
3. Desmet WJ, Vrolix MC, de Scheerder IK et al. Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty. Circulation 1994; 89: 385-392.
4. Kent KN, Williams DO, Cassagneau B et al. Double-blind, controlled trial of the effect of angiopeptin on coronary restenosis following coronary angioplasty (abstract). Circulation 1993; 88(suppl I): 594.
5. Serruys PW, Klein W, Tijssen JPG et al. Evaluation of ketanserin in the prevention of restenosis after PTCA. Circulation 1993; 88: 1588-1601.
6. Weintraub WS, Boccuzzi SJ, Klein JL et al. Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med 1994; 331: 1331-1337.
7. Waksman R, ed. Vascular brachytherapy, 2nd edn. Armonk NY: Futura Publishing Co. Inc., 1999.
8. Amols HI, Reinstein LE, Weinberger J. Dosimetry of a radioactive coronary balloon dilatation catheter for treatment of neointimal hyperplasia. Med Phys 1996; 23: 1783-1788.
9. 125I seed. Med Phys 1994; 21: 651-657.
10. McLaughlin WL, Chen YD, Soares CG et al. Sensitometry of the response of a new radiochromic film dosimeter to gamma radiation and electron beams. Nucl Instrum Methods, Phys Res 1991; 302: 165-176.
11. Niroomand A, Blackwell CR, Coursey BM et al. Radiochromic film dosimetry: recommendations of AAPM Radiation Therapy Committee Task Group 55. Med Phys 1998; 25: 2093-2115.
12. Calhoun JM, Cessna JT, Coursey BM et al. Standardization of holmium-166 by the CIEMAT/NIST liquid scintillation efficiency-tracing method. Radioact Radiochem 1992; 2: 38-45.
13. Browne E, Firestone RB. Table of radioactive isotopes. New York: Wiley-Interscience, 1986.
14. Firestone RB. Table of isotopes. New York: Wiley-Interscience, 1996.
15. Bayouth JE, Macey DJ, Kasi LP et al. Pharmacokinetics, dosimetry and toxicity of Holmium-166-DOTMP for bone marrow ablation in multiple myeloma. J Nucl Med 1995; 36: 730-737.
16. 90Y brachytherapy: preliminary dosimetric study using a specially modified angioplasty balloon. Int J Radiat Oncol Biol Phys 1995; 33: 713-717.